Latent Tuberculosis Infection in Korean Health Care Workers
NCT ID: NCT03010111
Last Updated: 2017-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2016-12-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ Assay
NCT00962793
Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
NCT01007396
QuantiFERON Change During Anti-tuberculosis Medication
NCT01038830
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098
Latent Tuberculosis Infection in Bone Marrow Transplant Recipients
NCT01021124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
health care workers
health care workers including doctors, nurses, technicians and orderly who were hired in 2016 at the Hanyang University Hospital
QFT-IT Test and other blood sampling
In all enrolled health care workers, QFT-IT Test and other blood sampling were performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QFT-IT Test and other blood sampling
In all enrolled health care workers, QFT-IT Test and other blood sampling were performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult aged 20-65
Exclusion Criteria
* Subjects diagnosed with HIV infection, malignancy
* Subjects having immunosuppressive drug therapy
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Won Park
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jang Won Shon, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Hanyang University Hospital, Seoul, Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYUMC_CM_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.